PRTA
Prothena Corporation PLC
Price:  
4.59 
USD
Volume:  
1,963,387.00
Ireland | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

PRTA WACC - Weighted Average Cost of Capital

The WACC of Prothena Corporation PLC (PRTA) is 7.4%.

The Cost of Equity of Prothena Corporation PLC (PRTA) is 10.00%.
The Cost of Debt of Prothena Corporation PLC (PRTA) is 5.00%.

Range Selected
Cost of equity 7.70% - 12.30% 10.00%
Tax rate 6.10% - 6.90% 6.50%
Cost of debt 5.00% - 5.00% 5.00%
WACC 6.2% - 8.5% 7.4%
WACC

PRTA WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.84 1.33
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.70% 12.30%
Tax rate 6.10% 6.90%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 6.2% 8.5%
Selected WACC 7.4%

PRTA's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for PRTA:

cost_of_equity (10.00%) = risk_free_rate (4.15%) + equity_risk_premium (5.10%) * adjusted_beta (0.84) + risk_adjustments (0.25%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.